Apr 20, 2015 - Just Accepted by Journal of Medical Economics. Inhaled nitric oxide in term/late preterm neonates with hypoxic respiratory failure: estimating ...
Just Accepted by Journal of Medical Economics
Inhaled nitric oxide in term/late preterm neonates with hypoxic respiratory failure: estimating the financial impact of earlier use G. Ganesh Konduri MD, Joseph Menzin PhD, Molly Frean BA, Terry Lee PhD, Jim Potenziano PhD, Joel Singer PhD doi: 10.3111/13696998.2015.1038270
Journal of Medical Economics Downloaded from informahealthcare.com by University of British Columbia on 04/20/15 For personal use only.
Abstract Objective: We reported recently that early use of inhaled nitric oxide therapy (iNO) for term and late preterm infants with hypoxic respiratory failure (HRF) at an oxygenation index (OI) of ≥15 and
